On October 20, 2017 The Medicines Company (NASDAQ:MDCO) reported that it will host a conference call on Wednesday, October 25, 2017, at 8:30 a.m., Eastern Time, to discuss its third-quarter 2017 financial results and operational developments (Press release, ImmunoGen, OCT 20, 2017, View Source [SID1234521055]).

A live audio webcast of the conference call may be accessed in the Investors section of The Medicines Company website. A replay of the webcast will be available on the website following the conference call.

The conference call may also be accessed by telephone as follows:

U.S./Canada: (877) 359-9508
International: (224) 357-2393
Conference ID: 9194649
A taped replay of the conference call will be available following the call and may be accessed as follows:

U.S./Canada: (855) 859-2056
International: (404) 537-3406
Conference ID: 9194649

On October 20, 2017 ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, reported that the Company will host a conference call at 8:00 a.m. ET on Friday, November 3, 2017 to discuss its third quarter 2017 financial results. Management also will provide a brief update on the business (Press release, ImmunoGen, OCT 20, 2017, View Source [SID1234521055]).

To access the live call by phone, dial 719-325-4907; the conference ID is 6498153. The call also may be accessed through the Investors section of the Company’s website, www.immunogen.com. Following the live webcast, a replay of the call will be available at the same location through November 17, 2017.

On October 20, 2017 ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, reported that the Company will host a conference call at 8:00 a.m. ET on Friday, November 3, 2017 to discuss its third quarter 2017 financial results. Management also will provide a brief update on the business (Press release, ImmunoGen, OCT 20, 2017, View Source [SID1234521055]).

To access the live call by phone, dial 719-325-4907; the conference ID is 6498153. The call also may be accessed through the Investors section of the Company’s website, www.immunogen.com. Following the live webcast, a replay of the call will be available at the same location through November 17, 2017.